UBS/CALL/ABBOTT LABORATORIES/125/0.1/20.12.24 Share Price

Warrant

CH1227466997

Delayed Deutsche Boerse AG 05:14:14 27/06/2024 pm IST
0.061 EUR -32.22% Intraday chart for UBS/CALL/ABBOTT LABORATORIES/125/0.1/20.12.24
Current month+57.89%
1 month-20.35%
Date Price Change
27/24/27 0.061 -32.22%
26/24/26 0.09 -5.26%
25/24/25 0.095 -20.83%
24/24/24 0.12 -4.00%
21/24/21 0.125 -13.19%

Delayed Quote Deutsche Boerse AG

Last update June 27, 2024 at 05:14 pm IST

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying ABBOTT LABORATORIES
Issuer UBS
WKN UL11GQ
ISINCH1227466997
Date issued 21/02/2023
Strike 125 $
Maturity 20/12/2024 (176 Days)
Parity 10 : 1
Emission price 0.75
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 0.9
Lowest since issue 0.049
Spread 0.1
Spread %62.11%

Company Profile

Abbott Laboratories specializes in the research, development, manufacturing and marketing of pharmaceutical and medical products. Net sales break down by family of products as follows: - diagnostic systems and instruments (39.1%); - vascular devices (24.7%): endoprosthetic systems, dilation catheters, arterial closures, etc.; - nutrition products (12.1%): pediatric nutrition products, nutritional supplements, and dietetic products; - medicine (8.2%): anesthetics, antiviral products, antibiotics, inhibitors, anti-inflammatories, etc.; - other (15.9%). Net sales are distributed geographically as follows: the United States (38.5%), Germany (5.8%), China (5.6%), India (4.4%), Switzerland (4.1%), Japan (3.8%), Netherlands (2.7%) and others (35.1%).
Sector
-
More about the company

Ratings for Abbott Laboratories

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: Abbott Laboratories

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
24
Last Close Price
104.9 USD
Average target price
125.2 USD
Spread / Average Target
+19.33%
Consensus